NCT00358033View on ClinicalTrials.gov

Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
DiabetesDyslipidemiaHypertensionCoronary Atherosclerosis
Interventions
BEHAVIORAL

Counseling

BEHAVIORAL

Interactive Education

BEHAVIORAL

Group Support

PROCEDURE

Pharmacologic case management

Provided by clinical pharmacists

Trial Locations (1)

02908

Providence VAMC, Providence

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Providence VA Medical Center

FED

NCT00358033 - Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic | Biotech Hunter | Biotech Hunter